All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

EFL060 - Topiramate and Metformin for Weight Loss in PCOS

Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent study in The Journal of Clinical Endocrinology & Metabolism that reports on the benefits of…

Read the full article
1y agoen

You might also wanna read

Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS

Conditions : Polycystic Ovary Syndrome (PCOS); Obesity; Infertility, Female Interventions : Drug: GLP-1 receptor agonist; Drug: Metformin Sp

clinicaltrials.gov·10d ago

Comparison between the effects of low-dose spironolactone plus metformin and metformin alone on hormonal and biochemical parameters of insulin resistance in women with polycystic ovary syndrome

Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-age women, characterized by insulin resistance a

ijrcog.org·21d ago

GLP-1 Prescriptions Surge Sevenfold Among Women With PCOS: What to Know About Off-Label Use

Wondering how GLP-1 drugs like Wegovy, Zepbound and Munjaro, work for people with PCOS? Here’s what you need to know.

pcosnutrition.com·10d ago

CME | A Practical Guide to PCOS and AUB

In this episode of CME on the Go, our hosts delve into the complex domain of women's health with a particular focus on abnormal uterine blee

28201698-87b5-4bd6-bf3a-bc85c6c0e2bd.libsyn.com·9mo ago

Can New Drugs Help Millions of Americans with Obesity?

Can New Drugs Help Millions of Americans with Obesity? Olivia Farrar Mon, 09/30/2024 - 12:01 More than 100 million Americans struggle with o

Harvard Magazine·1y ago

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Conditions : Overweight or Obesity Interventions : Drug: Olatorepatide; Drug: Placebo Sponsors : Regeneron Pharmaceuticals Not yet recruitin

clinicaltrials.gov·11d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.